Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Benefit of the Opti-Me Application to Inform SSRIs, SNRIs Medication Prescription or TMS Treatment for Subjects With a Primary Diagnosis of Major Depression Disorder (MDD)

NCT04148612 is registered in ClinicalTrials.gov with ElMindA Ltd as lead sponsor.

NCT NCT04148612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04148612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Benefit of the Opti-Me Application to Inform SSRIs, SNRIs Medication Prescription or TMS Treatment for Subjects With a Primary Diagnosis of Major Depression Disorder (MDD)
Lead sponsor
ElMindA Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
October 6, 2020
Completion date
January 31, 2022
Enrollment
390 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major